Cdk2 Is Required for p53-Independent G2/M Checkpoint Control

被引:87
作者
Chung, Jon H. [1 ]
Bunz, Fred
机构
[1] Johns Hopkins Univ, Sch Med, Dept Radiat Oncol & Mol Radiat Sci, Baltimore, MD 21218 USA
关键词
S-PHASE CHECKPOINT; CYCLIN-DEPENDENT KINASES; DNA-DAMAGE CHECKPOINT; HUMAN CANCER-CELLS; IONIZING-RADIATION; MAMMALIAN-CELLS; SOMATIC-CELLS; CDC6; ATR; ACTIVATION;
D O I
10.1371/journal.pgen.1000863
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
The activation of phase-specific cyclin-dependent kinases (Cdks) is associated with ordered cell cycle transitions. Among the mammalian Cdks, only Cdk1 is essential for somatic cell proliferation. Cdk1 can apparently substitute for Cdk2, Cdk4, and Cdk6, which are individually dispensable in mice. It is unclear if all functions of non-essential Cdks are fully redundant with Cdk1. Using a genetic approach, we show that Cdk2, the S-phase Cdk, uniquely controls the G(2)/M checkpoint that prevents cells with damaged DNA from initiating mitosis. CDK2-nullizygous human cells exposed to ionizing radiation failed to exclude Cdk1 from the nucleus and exhibited a marked defect in G(2)/M arrest that was unmasked by the disruption of P53. The DNA replication licensing protein Cdc6, which is normally stabilized by Cdk2, was physically associated with the checkpoint regulator ATR and was required for efficient ATR-Chk1-Cdc25A signaling. These findings demonstrate that Cdk2 maintains a balance of S-phase regulatory proteins and thereby coordinates subsequent p53-independent G(2)/M checkpoint activation.
引用
收藏
页数:11
相关论文
共 61 条
[31]   ATR (AT mutated Rad3 related) activity stabilizes Cdc6 and delays G2/M-phase entry during hydroxyurea-induced S-phase arrest of HeLa cells [J].
Liu, Linhua ;
Choi, Jae Hyuk ;
Yim, Hyungshin ;
Choi, Joon Seok ;
Park, Byoung Duck ;
Cho, Seung Ju ;
Lee, Seung Ki .
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2009, 41 (06) :1410-1420
[32]  
Liu QH, 2000, GENE DEV, V14, P1448
[33]   Functional genomic screens identify CINP as a genome maintenance protein [J].
Lovejoy, Courtney A. ;
Xu, Xin ;
Bansbach, Carol E. ;
Glick, Gloria G. ;
Zhao, Runxiang ;
Ye, Fei ;
Sirbu, Bianca M. ;
Titus, Laura C. ;
Shyr, Yu ;
Cortez, David .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2009, 106 (46) :19304-19309
[34]   Rapid destruction of human Cdc25A in response to DNA damage [J].
Mailand, N ;
Falck, J ;
Lukas, C ;
Syljuåsen, RG ;
Welcker, M ;
Bartek, J ;
Lukas, L .
SCIENCE, 2000, 288 (5470) :1425-1429
[35]   CDKs promote DNA replication origin licensing in human cells by protecting Cdc6 from APC/C-dependent proteolysis [J].
Mailand, N ;
Diffley, JFX .
CELL, 2005, 122 (06) :915-926
[36]   Mammalian cells cycle without the D-type cyclin-elependent kinases Cdk4 and Cdk6 [J].
Malumbres, M ;
Sotillo, R ;
Santamaria, D ;
Galán, J ;
Cerezo, A ;
Ortega, S ;
Dubus, P ;
Barbacid, M .
CELL, 2004, 118 (04) :493-504
[37]   Mammalian cyclin-dependent kinases [J].
Malumbres, M ;
Barbacid, M .
TRENDS IN BIOCHEMICAL SCIENCES, 2005, 30 (11) :630-641
[38]   Cell cycle, CDKs and cancer: a changing paradigm [J].
Malumbres, Marcos ;
Barbacid, Mariano .
NATURE REVIEWS CANCER, 2009, 9 (03) :153-166
[39]   Cdk2 is dispensable for cell cycle inhibition and tumor suppression mediated by p27Kip1 and p21Cip1 [J].
Martín, A ;
Odajima, J ;
Hunt, SL ;
Dubus, P ;
Ortega, S ;
Malumbres, M ;
Barbacid, M .
CANCER CELL, 2005, 7 (06) :591-598
[40]   Ataxia telangiectasia-mutated phosphorylates Chk2 in vivo and in vitro [J].
Matsuoka, S ;
Rotman, G ;
Ogawa, A ;
Shiloh, Y ;
Tamai, K ;
Elledge, SJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (19) :10389-10394